Blood product plasma pool "interim" limit of 60,000 donors endorsed by advisory committee.
BLOOD PRODUCT PLASMA POOL SIZE "INTERIM" UPPER LIMIT OF 60,000 DONORS RECOMMENDED by FDA's Blood Products Advisory Committee during its Sept. 18 meeting. The International Plasma Products Industry Association proposed adopting the 60,000 donor limit for Factor VIII, Factor IX, albumin and intravenous immunoglobulin. By a 7-1 vote, the committee accepted the proposal as an "interim" step in reducing donor pools used in manufacturing blood products.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth